T1	Participants 37 65	bone mineral density changes
T2	Participants 288 343	in 28 patients treated for 6 months with a GnRH agonist
T3	Participants 391 452	postmenopausal women with high bone turnover treated with HRT
T4	Participants 1609 1638	women with ovarian deficiency
